Experienced in Prostate Cancer

Eduardo H. Cronemberger

Fortaleza, CE, BR 
Experienced in Prostate Cancer
Fortaleza, CE, BR 
OverviewLocationsClinical Research

Overview

Eduardo Cronemberger practices in Fortaleza, Brazil. Mr. Cronemberger is rated as an Experienced expert by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Breast Cancer, Rectal Prolapse, Lung Cancer, and Prostate Cancer.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Prostate Cancer.

Gender
Male

Locations

Fortaleza, CE, Brazil
Other Locations
Porto Alegre, RS, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
Enrollment Status: Completed
Publish Date: February 20, 2024
Phase II Randomized Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
Phase II Randomized Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
Enrollment Status: Completed
Publish Date: July 07, 2021
Intervention Type: Drug
Study Drugs: Apalutamide, Abiraterone, ADT, Prednisone
Study Phase: Phase 2
View 1 Less Clinical Trial

15 Total Publications

Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).
Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).
Journal: Clinical breast cancer
Published: March 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cronemberger's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile